Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Organogenesis Holdings Inc. (AHPA)
|
Add to portfolio |
|
|
|
| Price: |
$10.00
| | Metrics |
| OS: |
131.3
|
M
| |
|
|
| Market cap: |
$1.31
|
B
| |
|
|
|
Net cash:
|
$19.9
|
M
| |
$0.15
|
per share
|
|
EV:
|
$1.29
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
$11.5
|
M
| |
112.6
|
x EV/EBIT
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| Revenues | 450.9 | 450.9 | 467.4 | 467.4 | 338.3 | 261.0 | 193.4 | 198.5 |
| Revenue growth | -3.5% | -3.5% | 38.2% | | 29.6% | 34.9% | -2.5% | 43.1% |
| Cost of goods sold | 105.0 | 105.0 | 114.2 | 114.2 | 87.3 | 75.9 | 68.8 | 61.2 |
| Gross profit | 345.9 | 345.9 | 353.2 | 353.2 | 251.0 | 185.0 | 124.6 | 137.3 |
| Gross margin | 76.7% | 76.7% | 75.6% | 75.6% | 74.2% | 70.9% | 64.4% | 69.2% |
| Selling, general and administrative | 283.8 | 283.8 | 250.2 | 250.2 | 204.2 | 200.1 | 162.0 | 133.7 |
| Research and development | 39.8 | 39.8 | 30.7 | 30.7 | 20.1 | 14.8 | 10.7 | 9.1 |
| EBITA | 27.2 | 22.3 | 77.2 | 72.2 | 30.4 | -23.8 | -47.9 | -3.5 |
| EBITA margin | 6.0% | 4.9% | 16.5% | 15.5% | 9.0% | -9.1% | -24.8% | -1.7% |
| Amortization of intangibles | 4.9 | | 4.9 | | 3.7 | 6.0 | 3.7 | 2.0 |
| EBIT | 22.3 | 22.3 | 72.2 | 72.2 | 26.7 | -29.9 | -51.6 | -5.5 |
| EBIT margin | 4.9% | 4.9% | 15.5% | 15.5% | 7.9% | -11.4% | -26.7% | -2.8% |
| Pre-tax income | 20.3 | 20.3 | 63.1 | 63.1 | 17.8 | -38.6 | -64.7 | -14.6 |
| Income taxes | 4.8 | 4.8 | -31.1 | -31.1 | 0.5 | 0.2 | 0.1 | -7.0 |
| Tax rate | 23.4% | 23.4% | | | 3.0% | | | 48.3% |
| Net income | 15.5 | 15.5 | 94.2 | 94.2 | 17.2 | -39.3 | -64.8 | -8.8 |
| Net margin | 3.4% | 3.4% | 20.2% | 20.2% | 5.1% | -15.0% | -33.5% | -4.4% |
| |
| Diluted EPS | $0.12 | $0.12 | $0.70 | $0.70 | $0.15 | ($0.42) | ($0.94) | ($0.14) |
| Shares outstanding (diluted) | 132.4 | 132.4 | 133.7 | 133.7 | 111.4 | 92.8 | 69.3 | 63.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|